Sector Gamma ASA »

Crinetics Pharmaceuticals In shares owned by Sector Gamma ASA

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Sector Gamma ASA from 13F filings

Historical chart of Sector Gamma ASA investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Sector Gamma ASA

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4M 115k 46.55

More positions owned by Sector Gamma ASA

Bristol Myers Squibb (BMY)
Merck & Co (MRK)
Medtronic SHS (MDT)
Becton, Dickinson and (BDX)
Gilead Sciences (GILD)
Incyte Corporation (INCY)
Pfizer (PFE)
Amgen (AMGN)
Biogen Idec (BIIB)
Ionis Pharmaceuticals (IONS)
CVS Caremark Corporation (CVS)
Cardinal Health (CAH)
Thermo Fisher Scientific (TMO)
Bruker Corporation (BRKR)
Zimmer Holdings (ZBH)

View all positions for Sector Gamma ASA

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Baker Bros. Advisors
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In